highly significantP < .0001
However, patients with a high FRET efficiency (Fig 4 B) had considerably better survival (highly significant P < .0001) in first-line treatments compared with low FRET patients (median 50% survival still undefined after 50 months for high FRET v 11 months for low FRET patients).